APPLICATION
ANDA216160
TYPE
ANDA
ORIGINAL APPROVAL
2024-04-22
LATEST ACTION
2024-04-22
ROUTE
TOPICAL, TRANSDERMAL
DOSAGE FORM
GEL, METERED
MARKETING STATUS
Prescription
Products
ESTRADIOLPrescription
ESTRADIOL 0.06% (1.25GM/ACTIVATION) · GEL, METERED · TRANSDERMAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.